1. Report Overview

1.1 Overview of the Global Advanced Wound Care Market

1.3 Benefits of This Report

1.4 Report Structure

1.5 Who is This Report For?

1.6 Methodology

1.6.1 Primary Research

1.6.2 Secondary Research

1.7 Frequently Asked Questions (FAQs)

1.8 Associated Visiongain Reports

1.9 About Visiongain

2. Introduction to the Advanced Wound Care Market

2.1 Advanced Wound Care Market Definition

2.1.1 Definition of Wound

2.1.2 Types of Wound

2.2 Advanced Wound Care Market Segmentation

2.2.1 Advanced Wound Care Market by Therapy

2.2.1.1 Traditional wound care

2.2.1.2 Advanced Wound Care

2.2.2 Advanced Wound Care Market by Biologics

2.2.2.1 Skin Replacement Therapies

2.2.2.2 Collagen-Based Therapies

2.2.2.3 Cell-Based Therapies

2.2.3 Advanced Wound Care market by Devices

2.2.3.1 Negative Pressure Wound Therapy (NPWT)

2.2.3.2 Ultrasound for Wound Therapy

2.3 Demand for Advanced Wound Care in Regional Markets

2.3.1 Americas Advanced Wound Care Market Overview - 2018

2.3.2 Europe Advanced Wound Care Market Overview- 2018

2.3.3 Asia-Pacific Advanced Wound Care Market 2018

3. Global Advanced Wound Care Market, 2018

3.1 Global Advanced Wound Care Market 2018 Overview

3.2 The World Advanced Wound Care Market: Industry Trends, 2018-2029

3.3 Drivers and Challenges for the Global Advanced Wound Care Market

3.3.1 Drivers

3.3.1.1 Increase in Aging Population:

3.3.1.2 Lifestyle Factors

3.3.1.3 Growing Incidence of Diabetes, Ulcers and Chronic Wounds

3.3.1.4 Technological Advancements and Government Initiatives

3.3.2 Challenges

3.3.2.1 High Cost Procedures

3.3.2.2 Disparity in Reimbursements

3.3.2.3 Reluctance to Accept New Technologies

3.3.3 Opportunities

3.3.3.1 Significant Growth Opportunities in Asia-Pacific and Developing Countries

3.3.3.2 Healthy Growth in the Active Wound Care Market

4. Leading 20 Companies Positioning in the Advanced Wound Care Market

4.1 Leading 20 Companies Ranking in the Advanced Wound Care Market

4.2 Global Advanced Wound Care Market Forecast, 2018-2029

5. Top 20 Advanced Wound Care Companies

5.1 Smith & Nephew Plc. Overview

5.1.1 Smith & Nephew Plc. Financial Outlook

5.1.2 Smith & Nephew Plc Product Portfolio

5.1.3 Smith & Nephew Plc Strategic Developments

5.2 Acelity (KCI and Systagenix) Overview

5.2.1 Acelity L.P. Inc. Financial Outlook

5.2.2 Acelity L.P. Inc. Product Portfolio

5.2.3 Acelity L.P. Inc. Strategic Developments

5.3 Mölnlycke Health Care AB Overview

5.3.1 Mölnlycke Financial Outlook

5.3.2 Mölnlycke Product Portfolio

5.3.3 Mölnlycke Strategic Developments

5.4 ConvaTec Group Plc Overview

5.4.1 ConvaTec Group Plc Financial Outlook

5.4.2 ConvaTec Group Plc Product Portfolio

5.4.3 ConvaTec Group Plc Strategic Developments

5.5 Coloplast A/S Overview

5.5.1 Coloplast A/S Financial Outlook

5.5.2 Coloplast A/S Product Portfolio

5.5.3 Coloplast A/S Strategic Developments

5.6 3M Company Overview

5.6. 3M Company Financial Outlook

5.6.2 3M Company Product Portfolio

5.6.3 3M Company Strategic Developments

5.7 B. Braun Melsungen AG Overview

5.7.1 B. Braun Melsungen AG Financial Outlook

5.7.2 B. Braun Melsungen AG Product Portfolio

5.7.3 B. Braun Melsungen AG Strategic Developments

5.8 BSN Medical GmbH Overview

5.8.1 BSN Medical GmbH Financial Outlook

5.8.2 BSN Medical GmbH Product Portfolio

5.8.3 BSN Medical GmbH Strategic Developments

5.9 Cardinal Health, Inc. Overview

5.9.1 Cardinal Health, Inc. Financial Outlook

5.9.2 Cardinal Health, Inc. Product Portfolio

5.9.3 Cardinal Health, Inc. Strategic Developments

5.10 Generex Biotechnology Corp. Overview

5.10.1 Generex Biotechnology Corp.Financial Outlook

5.10.2 Generex Biotechnology Corp. Product Portfolio

5.10.3 Generex Biotechnology Corp. Strategic Developments

5.11 Hill-Rom Holdings, Inc. Overview

5.11.1 Hill-Rom Holdings, Inc.Financial Outlook

5.9.2 Hill-Rom Holdings, Inc. Product Portfolio

5.11.3 Hill-Rom Holdings, Inc. Strategic Developments

5.12 Hollister, Inc. Overview

5.12.1 Hollister, Inc. Financial Outlook

5.12.2 Hollister, Inc. Product Portfolio

5.13 Integra LifeSciences Holdings Corporation Overview

5.13.1 Integra LifeSciences Holdings Corporation Financial Outlook

5.9.2 Integra LifeSciences Holdings Corporation Product Portfolio

5.13.3 Integra LifeSciences Holdings Corporation Strategic Developments

5.14 Lohmann & Rauscher GmbH & Co. Kg Overview

5.14.1 Lohmann & Rauscher GmbH & Co. Kg Financial Outlook

5.14.2 Lohmann & Rauscher GmbH & Co. Kg Product Portfolio

5.14.3 Lohmann & Rauscher GmbH & Co. Kg Strategic Developments

5.15 Medline Industries, Inc. Overview

5.15.1 Medline Industries, Inc. Financial Outlook

5.15.2 Medline Industries, Inc. Product Portfolio

5.16 Medtronic PLC Overview

5.16.1 Medtronic PLC Financial Outlook

5.16.2 Medtronic PLC Product Portfolio

5.16.3 Medtronic PLC Strategic Developments

5.17 Organogenesis Inc. Overview

5.17.1 Organogenesis Inc.Financial Outlook

5.17.2 Organogenesis Inc. Product Portfolio

5.17.3 Organogenesis Inc. Strategic Developments

5.18 PAUL HARTMANN AG Overview

5.18.1 PAUL HARTMANN AG Financial Outlook

5.18.2 PAUL HARTMANN AG Product Portfolio

5.19 Celularity, Inc.Overview

5.19.1 Celularity, Inc. Financial Outlook

5.19.2 Celularity, Inc. Product Portfolio

5.19.3 Celularity, Inc. Strategic Developments

5.20 Johnson & Johnson Overview

5.20.1 Johnson & Johnson Financial Outlook

5.5.2 Johnson & Johnson Product Portfolio

6 SWOT Analysis of the Global Advanced Wound Care Market

6.1 Strengths

6.2 Weaknesses

6.3 Opportunities

6.4 Threats

7. Conclusion

7.1 Continuous Innovation and a Strong R&D Pipeline

7.2 Higher Effectiveness Compared with Other Treatments

7.3 An Oligopolistic Market

7.4 Top 20 Companies and Revenue

Appendices

Associated Visiongain Reports

Visiongain Report Sales Order Form

About Visiongain

Visiongain Report Evaluation Form

List of Tables

Table 2.1 The Global Advanced Wound Care Market Revenue Forecast ($bn), 2018-2029

Table 2.2 The North America Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029

Table 2.3 The Europe Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029

Table 2.4 Asia-pacific Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029

Table 4.1 Companies Profiled in this Report and Country HQ

Table 4.2 Global Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029

Table 5.1 Smith & Nephew Plc.: Key Facts, 2019

Table 5.2 Smith & Nephew Plc.: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018

Table 5.3 Smith & Nephew Plc.: Product Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018

Table 5.4 Smith & Nephew Plc.: Advanced Wound Management Revenue ($million), AGR (%) 2016-2018

Table 5.5 Smith & Nephew Plc.: Advanced Wound Management Product Revenue ($million) and Revenue Shares (%), 2018

Table 5.6 Smith & Nephew Plc.: Strategic Developments, 2015-2019

Table 5.7 Acelity L.P. Inc.: Key Facts, 2019

Table 5.8 Acelity L.P. Inc.: Strategic Developments, 2015-2019

Table 5.9 Mölnlycke: Key Facts, 2019

Table 5.10 Mölnlycke: Strategic Developments, 2015-2019

Table 5.11 ConvaTec Group Plc: Key Facts, 2019

Table 5.12 ConvaTec Group Plc: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018

Table 5.13 ConvaTec Group Plc: Advanced Wound Care Revenue ($million), AGR (%) 2016-2018

Table 5.14 ConvaTec Group Plc: Strategic Developments, 2015-2019

Table 5.15 Coloplast A/S: Key Facts, 2018

Table 5.16 Coloplast A/S: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018

Table 5.17 Coloplast A/S: Wound & Skin Care Revenue ($million), AGR (%) 2016-2018

Table 5.18 Coloplast A/S: Strategic Developments, 2015-2019

Table 5.19 3M Company: Key Facts, 2019

Table 5.20 3M Company: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018

Table 5.21 3M Company: Strategic Developments, 2015-2018

Table 5.22 B. Braun Melsungen AG: Key Facts, 2019

Table 5.23 B. Braun Melsungen AG: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2017

Table 5.24 B. Braun Melsungen AG: Outpatient Revenue ($million), AGR (%) 2015-2017

Table 5.25 B. Braun Melsungen AG: Strategic Developments, 2015-2018

Table 5.26 BSN Medical GmbH: Key Facts, 2018

Table 5.27 BSN Medical GmbH: Strategic Developments, 2015-2018

Table 5.28 Cardinal Health, Inc.: Key Facts, 2019

Table 5.29 Cardinal Health, Inc.: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018

Table 5.30 Cardinal Health, Inc.: Medical Segment Revenue ($million), AGR (%) 2016-2018

Table 5.31 Cardinal Health, Inc.: Strategic Developments, 2015-2019

Table 5.32 Generex Biotechnology Corp.: Key Facts, 2019

Table 5.33 Generex Biotechnology Corp.: Strategic Developments, 2015-2019

Table 5.34 Hill-Rom Holdings, Inc.: Key Facts, 2019

Table 5.35 Hill-Rom Holdings, Inc.: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018

Table 5.36 Hill-Rom Holdings, Inc.: Healthcare Revenue ($million), AGR (%) 2016-2018

Table 5.37 Hill-Rom Holdings, Inc.: Strategic Developments, 2015-2018

Table 5.38 Hollister, Inc.: Key Facts, 2018

Table 5.39 Integra LifeSciences Holdings Corporation: Key Facts, 2019

Table 5.40 Integra LifeSciences Holdings Corporation: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018

Table 5.41 Integra LifeSciences Holdings Corporation: Orthopedics & Tissue Technologies Revenue ($million), AGR (%) 2016-2018

Table 5.42 Integra LifeSciences Holdings Corporation: Strategic Developments, 2015-2018

Table 5.43 Lohmann & Rauscher GmbH & Co. Kg: Key Facts, 2018

Table 5.44 Lohmann & Rauscher GmbH & Co. Kg: Strategic Developments, 2015-2018

Table 5.45 Medline Industries, Inc.: Key Facts, 2018

Table 5.46 Medtronic PLC: Key Facts, 2018

Table 5.47 Medtronic PLC: Revenue ($million) and Revenue Shares (%) by Segment, 2018

Table 5.48 Medtronic PLC: Minimally Invasive Therapies Group Revenue ($million), AGR (%) 2016-2018

Table 5.49 Medtronic PLC: Minimally Invasive Product Revenue ($million) and Revenue Shares (%), 2018

Table 5.50 Medtronic PLC: Strategic Developments, 2015-2018

Table 5.51 Organogenesis Inc.: Key Facts, 2018

Table 5.52 Organogenesis Inc.: Strategic Developments, 2015-2018

Table 5.53 PAUL HARTMANN AG: Key Facts, 2019

Table 5.54 PAUL HARTMANN AG: Revenue ($million) and Revenue Shares (%) by Segment, 2018

Table 5.55 PAUL HARTMANN AG: Wound Management Revenue ($million), AGR (%) 2017-2018

Table 5.56 Celularity, Inc.: Key Facts, 2019

Table 5.57 Celularity, Inc.: Strategic Developments, 2015-2018

Table 5.58 Johnson & Johnson: Key Facts, 2019

Table 5.59 Johnson & Johnson: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018

Table 5.60 Johnson & Johnson: Product Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018

Table 5.61 Johnson & Johnson: Wound Care/Other Revenue ($million), AGR (%) 2016-2018

Table 7.1 Top 20 Companies and Revenue, 2018 ($million)

List of Figures

Figure 4.1 Market share of key companies in advanced wound care market (%), 2018

Figure 4.2 Global Advanced Wound Care Market Revenue ($bn), 2018-2029

Figure 5.1 Smith & Nephew Plc.: Historical Revenues ($million, 2014-2018

Figure 5.2 Smith & Nephew Plc.: Revenue Shares (%) by Reporting Segment, 2018

Figure 5.3 Smith & Nephew Plc.: Revenue Shares (%) by Reporting Segment, 2018

Figure 5.4 Smith & Nephew Plc.: Revenue Shares (%) by Region, 2018

Figure 5.5 Smith & Nephew Plc: Advanced Wound Management Revenue ($million), 2016-2018

Figure 5.6 Smith & Nephew Plc.: Advanced Wound Management Product Revenue Shares (%), 2018

Figure 5.7 Mölnlycke : Historical Revenues ($million), 2014-2018

Figure 5.8 ConvaTec Group Plc: Historical Revenues ($million), 2014-2018

Figure 5.9 ConvaTec Group Plc: Revenue Shares (%) by Reporting Segment, 2018

Figure 5.10 ConvaTec Group Plc: Revenue Shares (%) by Region, 2018

Figure 5.11 ConvaTec Group Plc: Advanced Wound Care Revenue Shares (%), 2016-2018

Figure 5.12 Coloplast A/S: Historical Revenues ($million), 2014-2018

Figure 5.13 Coloplast A/S: Revenue Shares (%) by Reporting Segment, 2018

Figure 5.14 Coloplast A/S: Revenue Shares (%) by Region, 2018

Figure 5.15 Coloplast A/S: Wound & Skin Care Revenue ($million), 2016-2018

Figure 5.16 3M Company: Historical Revenues ($million), 2014-2018

Figure 5.17 3M Company: Revenue Shares (%) by Reporting Segment, 2018

Figure 5.18 3M Company: Revenue Shares (%) by Region, 2018

Figure 5.19 B. Braun Melsungen AG: Historical Revenues ($million), 2013-2017

Figure 5.20 B. Braun Melsungen AG: Revenue Shares (%) by Reporting Segment, 2017

Figure 5.21 B. Braun Melsungen AG: Revenue Shares (%) by Region, 2017

Figure 5.22 B. Braun Melsungen AG: Outpatient Revenue ($million), 2015-2017

Figure 5.23 Cardinal Health, Inc.: Historical Revenues ($million), 2014-2018

Figure 5.24 Cardinal Health, Inc.: Revenue Shares (%) by Reporting Segment, 2018

Figure 5.25 Cardinal Health, Inc.: Revenue Shares (%) by Region, 2018

Figure 5.26 Cardinal Health, Inc.: Medical Segment Revenue ($million), 2016-2018

Figure 5.27 Hill-Rom Holdings, Inc.: Historical Revenues ($million), 2014-2018

Figure 5.28 Hill-Rom Holdings, Inc.: Revenue Shares (%) by Reporting Segment, 2018

Figure 5.29 Hill-Rom Holdings, Inc.: Revenue Shares (%) by Region, 2018

Figure 5.30 Hill-Rom Holdings, Inc.: Healthcare Revenue ($million), 2016-2018

Figure 5.31 Integra LifeSciences Holdings Corporation: Historical Revenues ($million), 2014-2018

Figure 5.32 Integra LifeSciences Holdings Corporation: Revenue Shares (%) by Reporting Segment, 2018

Figure 5.33 Integra LifeSciences Holdings Corporation: Revenue Shares (%) by Region, 2018

Figure 5.34 Integra LifeSciences Holdings Corporation: Orthopedics & Tissue Technologies Revenue ($million), 2016-2018

Figure 5.35 Medtronic PLC: Historical Revenues ($million), 2014-2018

Figure 5.36 Medtronic PLC: Revenue Shares (%) by Segment, 2018

Figure 5.37 Medtronic PLC: Revenue Shares (%) by Product Type, 2018

Figure 5.38 Medtronic PLC: Revenue Shares (%) by Region, 2017

Figure 5.39 Medtronic PLC: Minimally Invasive Therapies Group Revenue ($million), 2016-2018

Figure 5.40 Medtronic PLC: Minimally Invasive Product Revenue Shares (%), 2018

Figure 5.42 PAUL HARTMANN AG: Revenue Shares (%) by Product Type, 2018

Figure 5.43 PAUL HARTMANN AG: Revenue Shares (%) by Region, 2018

Figure 5.44 PAUL HARTMANN AG: Wound Management Revenue ($million), 2017-2018

Figure 5.45 PAUL HARTMANN AG: Wound Management Revenue by Region($million), 2018

Figure 5.46 Johnson & Johnson: Historical Revenues ($million), 2014-2018

Figure 5.47 Johnson & Johnson: Revenue Shares (%) by Reporting Segment, 2018

Figure 5.48 Johnson & Johnson: Revenue Shares (%) by Product, 2018

Figure 5.49 Johnson & Johnson: Revenue Shares (%) by Region, 2018

Figure 5.50 Johnson & Johnson: Wound Care/Other Revenue ($million), 2016-2018

Figure 5.51 Johnson & Johnson: Wound Care/Other Revenue by Region ($million), 2018

Figure 6.1 SWOT Analysis of the Global Advanced Wound Care Market, 2019